TUESDAY, June 29 (HealthDay News) -- The first generic version of Effexor extended release capsules (venlafaxine hydrochloride) to treat major depressive disorder has been approved by the U.S. Food and Drug Administration.
Latest Depression News
Prescribing information for the generic version of Effexor XR may differ from that of the brand name drug because of various patents held by the brand name drug's maker, Wyeth Pharmaceuticals, the FDA said in a news release. But the same safety warnings will apply.
The generic version will be manufactured by Teva Pharmaceuticals, based in Wales, Penn.
-- Scott Roberts
Copyright © 2010 HealthDay. All rights reserved.
Subscribe to MedicineNet's Depression Newsletter